Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

National AI usage among businesses is 9.2%, with a projected increase to 11.6% in six months. Utah leads state AI business adoption at 15.7%%; Delaware's projected rate is highest at 19.1%.

Brinsupri FDA approval, with strong sales potential and M&A interest. Click here to find out why INSM stock is a Buy.

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...